QINGLONG MIAO to CD8-Positive T-Lymphocytes
This is a "connection" page, showing publications QINGLONG MIAO has written about CD8-Positive T-Lymphocytes.
Connection Strength
0.219
-
Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy. Cell Rep. 2024 11 26; 43(11):114875.
Score: 0.181
-
BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy. Cancer Immunol Res. 2022 05 03; 10(5):597-611.
Score: 0.038